[Efficacy of first generation EGFR-TKIs and chemotherapy as first-line therapy in advanced lung adenocarcinoma patients with uncommon EGFR mutations].
Year: 2019
Type: article
Source: PubMed
Authors: H X Li, Z Z Wang, G W Zhang, M N Zhang, X X Zheng, J P Yang, Z Y Ma, H J Wang
Language: Chinese
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2983264751
